8-K - Immuneering Corporation | StockGist

Current Report Details

Event Type

Material Agreement

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. On September 24, 2025, Immuneering Corporation (the “Company”) entered into an underwriting agreement (the “Underw

Material Agreement

$9.23$25.0M$75.0M$164.1M

8.01

. Other Events. On August 13, 2025, the Company entered into an equity distribution agreement with Piper Sandler & Co. relating to the sale of shares of the Com

Other Event

$100.0M$1.3M$98.7M

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated as of September 24, 2025, by and between Immuneering

Exhibits Only

Exhibits (3)

1.1

EXHIBIT 1.1

5.1

EXHIBIT 5.1

8-K

FORM 8-K